Getinge AB (GNGBY)
21.28
-0.04
(-0.19%)
USD |
OTCM |
Apr 23, 11:46
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.796B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -15.68% |
| Valuation | |
| PE Ratio | 25.51 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.928 |
| Price to Book Value | 1.934 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.4164 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.2187 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 66.67% |
Profile
| Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%. |
| URL | https://www.getinge.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Apr. 26, 2024 (est.) |
| Last Earnings Release | Feb. 01, 2024 |
| Next Ex-Dividend Date | Apr. 23, 2024 |
| Last Ex-Dividend Date | Apr. 23, 2024 |
Ratings
Profile
| Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%. |
| URL | https://www.getinge.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Apr. 26, 2024 (est.) |
| Last Earnings Release | Feb. 01, 2024 |
| Next Ex-Dividend Date | Apr. 23, 2024 |
| Last Ex-Dividend Date | Apr. 23, 2024 |